Skip to content
Company Analysis

Catheter Precision, Inc. VTAK

A comprehensive view of key metrics, scores, and financial health for Catheter Precision, Inc.

Overview of Catheter Precision, Inc.

VTAK ASE
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Catheter Precision, Inc. (VTAK), is a Micro Cap company, in the Medical Devices industry, last closed at $0.65, about 0.0% overvalued vs fair value, -74.6% 1Y return, ranked 606/1145 in sector.
Metrics Rev Growth 95.0% ROE -182.7% Gross Margin 92.3%
USD 0.65
-8.45%
(Delayed)
• Vol 90d: 209.2%
Market Cap
$2.16M
Enterprise Value
$12.12M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Good
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 88%
Confidence: 88%
Updated: Oct 25
Top Beats

Quick Facts

Website https://www.catheterprecision....
HQ Fort Mill, SC
Employees 22
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-2
$-2
$-2
Current: $0.65

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$819.0K
95%%
Gross Profit
$756.0K
100%%
Operating Income (GAAP)
-$21.1M
-88.1%%
EBITDA
-$17.1M
-51.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
92.3%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$5.2M

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
1/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Catheter Precision, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
44
/100
Developing
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Elite Gross Margins Gross margin quality is top-tier vs peers (score 0.98). This signals strong consumable attach-rate economics.
  • Improving FCF Trend FCF trend score is positive (score 0.98). Improving FCF margin signals compounding operational leverage.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.15). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Weak FCF Generation FCF margin quality lags peers (score 0.17). Below-peer FCF conversion is a MedTech quality warning.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
59
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 87% Coverage
Trade-Off Triangle Visualization A ternary plot showing VTAK's balance between Growth (57.3%), Profitability (23.0%), and Safety (19.7%). Growth 57% Safety 20% Profitability 23%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

76th percentile vs peers
77
Key Signals
Rev Growth YoY 95.0% 95p Revenue CAGR 3Y 2.88 97p EPS Growth YoY 83.6% 81p TSR -72.7% 5p Asset Growth YoY -42.9% 3p
Strengths
  • Rev Growth YoY in top 20% of peers (95.0%, 95th percentile)
  • Revenue CAGR 3Y in top 20% of peers (2.88, 97th percentile)
  • EPS Growth YoY in top 20% of peers (83.6%, 81th percentile)
  • Gross Profit Margin in top 20% of peers (92.3%, 96th percentile)
  • Growth above peer median with strong metric coverage (85%)
Risks

No significant risks identified for this axis.

Profitability

30th percentile vs peers
31
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

26th percentile vs peers
26
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Catheter Precision, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-1.92
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000